<DOC>
	<DOCNO>NCT03059173</DOCNO>
	<brief_summary>The main objective check MyoInositol ( MYO ) reduce total resistance rate Clomiphene Citrate ( CC ) . For , study control , randomize double blind . It include patient PCOS ( polycystic ovary syndrome , define Rotterdam criterion ) wish become pregnant eligible simple ovulation induction CC . Half receive MYO + folic acid ( FA ) addition CC , half receive placebo contain FA addition CC . The MYO supplementation initiate least one month take CC continue throughout treatment pregnancy switch another type treatment ovulation induction pregnancy obtain 6 ovulatory cycle .</brief_summary>
	<brief_title>Interest Myo-inositol Supplementation Women With Polycystic Ovarian Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Wishing pregnancy , Having PCOS define Rotterdam criterion : high antral follicle count ( AFC ) ( &gt; 19 per ovary ) and/or disorder cycle and/or hyperandrogenism ( least two three criterion ) , Having never treat CC ( previous treatment CC interrupt &gt; 3 month ) . Having receive complete information sign consent . Covered social security Intolerance CC previous treatment , BMI &gt; 35 , Other associate cause oligoanovulation require specific treatment ( eg. , Hyperprolactinemia functional hypothalamic anovulation ) , Ongoing pregnancy time CC initiation , Other male female cause hypofertility , History ovarian drilling , Negative rubella serology .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>Reproductive medicine</keyword>
</DOC>